24th April, 2025
The regulatory milestone paves the way for broader adoption of its neuroimaging solutions across North America.
Cortechs.ai, a global leader in AI-driven medical imaging analysis, is proud to announce that that it has received approval from Health Canada for the sale of its innovative suite of imaging solutions. This regulatory milestone marks a significant expansion of Cortechs.ai's presence in the Canadian healthcare market and reinforces its commitment to enhancing clinical diagnostics and radiology workflows worldwide.
Cortechs.ai's advanced portfolio includes NeuroQuant®, NeuroQuant® MS, OnQ™ Prostate, and NeuroQuant® Brain Tumor. These software tools harness advanced AI to streamline complex imaging analysis, equipping clinicians with accurate insights that enhance disease assessment and validation across various care pathways.
NeuroQuant® and NeuroQuant® MS offer automated segmentation and volumetric analysis of brain MRI, aiding in the assessment and monitoring of neurodegenerative diseases such as Alzheimer's and Multiple Sclerosis. NeuroQuant® Brain Tumor delivers quantitative MR imaging analysis to assist clinicians in interpreting neurological MR images when evaluating brain tumors, while OnQ™ Prostate enhances prostate MRI interpretation, allowing for a more precise evaluation of prostate cancer.
"This Health Canada approval is a monumental achievement for Cortechs.ai and a testament to our dedication to transforming diagnostic imaging," said Jared Dixon, VP of Global Sales at Cortechs.ai. "Expanding access to our AI-powered solutions in Canada means that more clinicians will have the tools they need to make faster, more accurate diagnoses and improve patient outcomes. This is a major step forward for our company's growth and our mission to revolutionize disease detection and treatment across the globe."
With this approval, Cortechs.ai is poised to collaborate with healthcare providers and institutions across Canada, equipping them with cutting-edge solutions that optimize clinical workflows and elevate patient care.
Medtech Special
Artificial Intelligence Breakthroughs
Robots In Medtech
Asia Pacific
Global / International
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer